Form D · Other Technology

Sudo Biosciences, Inc.

Carmel, IN · CIK 0001860521

Offering snapshot reported Feb 15, 2024 · SEC filing

Reported sold: $63.6M
Investors reported: 15
Minimum accepted: $0
First sale: Dec 15, 2023

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$53,346,588 → $63,596,587
Reported investors12 → 15

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 15, 2024	Amendment	$63,596,587	$10,249,999vs Dec 28, 2023	15	SEC filing
Dec 28, 2023	Initial	$53,346,588	No comparison	12	SEC filing
Mar 2, 2022	Amendment	$22,250,000	$12,726,190vs May 5, 2021	6	SEC filing
May 5, 2021	Initial	$9,523,810	No comparison	1	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-501000

Source: Form D, filed Feb 15, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Jim Bristol	Director
Scott Byrd	Director, Executive
Bhaskar Chaudhuri	Director
Daniel Estes	Director
Edd Fleming	Director
Shinichiro Fuse	Director
Chris Gagliardi	Director
David Johnson	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

10401 N. Meridian Street Suite 225
Carmel, IN, 46290